Renal functional state in patients with myocardial infarction

  • Authors: Kurochkina ON1, Khokhlov AL2, Bogomolov AN3
  • Affiliations:
    1. Коми филиал Кировской государственной медицинской академии Минздрава РФ
    2. Ярославская государственная медицинская академия Минздрава РФ
    3. Военно-медицинская академия им. С.М. Кирова, Санкт-Петербург
  • Issue: Vol 85, No 4 (2013)
  • Pages: 56-60
  • Section: Editorial
  • URL: https://journals.rcsi.science/0040-3660/article/view/31244
  • ID: 31244

Cite item

Full Text

Abstract

AIM: To study renal dysfunction in patients with myocardial infarction (MI)/MATERIAL AND METHODS: 670 case histories of patients diagnosed with acute coronary syndrome, including 369 (55.8%) men and 292 (44.2%) women at the age of 33 to 85 years (mean age 64.8±11.7 years), were retrospectively studied. The authors considered comorbidities and analyzed complaints, history data, and the results of physical examinations, biochemical blood tests for plasma glucose, troponin, MB fractions of creatine phosphokinase and creatinine, and cholesterol in all the patients. Instrumental studies involved electro- and echocardiography. Glomerular filtration rate (GFR) was estimated using the MDRD formula. The patients were divided into groups according to GFR values: 1) >90 ml/min/1.73 m2; 2) 60 to 89 ml/min/1.73 m2; 3) 30 to 59 ml/min/1.73 m2; 4) less than 30 ml/min/1.73 m2/RESULTS: Most patients were found to have a moderate or significant reduction in kidney function. Worsening renal function in patients with MI was associated with advanced patient age, the lower proportion of men in the patient structure, the higher prevalence of concomitant cardiovascular diseases, such as arterial hypertension, chronic heart failure, and prior MI, and diabetes mellitus/CONCLUSION: The findings suggest that kidney dysfunction is of essential value in developing the multiplicity of comorbidities in patients with MI. The wide introduction of a GFR calculating method in daily medical practice will be able to adequately and timely identify renal filtration function and to make a correction into a treatment regimen, thus decreasing the number of poor outcomes.

About the authors

O N Kurochkina

Коми филиал Кировской государственной медицинской академии Минздрава РФ

Email: olga_kgma@mail.ru

A L Khokhlov

Ярославская государственная медицинская академия Минздрава РФ

A N Bogomolov

Военно-медицинская академия им. С.М. Кирова, Санкт-Петербург

References

  1. The ESC Task Force for diagnosis and treatment of non-ST-elevation acute coronary syndromes. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28 (13): 1598-1660.
  2. Brooks M.M., Jones R.H., Bach R.G. et al. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. Circulation 2000; 101: 2682-2689.
  3. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
  4. Joki N., Hase H., Nakamura R., Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723.
  5. van Domburg R.T., Hoeks S.E., Welten G.M. et al. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 2008; 19: 158-163.
  6. Levey A.S., Beto J.A., Coronado B.E. et al. Controlling the epidemic of cardiovascular disease in chronic renal disease. National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906.
  7. Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
  8. Tonelli M., Wiebe N., Culleton B. et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034-2047.
  9. van Domburg R.T., Hoeks S.E., Welten G.M.J.M. et al. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Neph 2008; 19: 158-163.
  10. Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 2000; 21: 2005-2013.
  11. Cannon C.P., McCabe C.H., Gibson C.M. et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) 10A-ranging trial. Circulation 1997; 95 (2): 351-356.
  12. Jihyun Son, Seung-Ho Hur, In Cheol Kim et al. The Impact of Moderate to Severe Renal Insufficiency on Patients With Acute Myocardial Infarction. Korean Circ J 2011; 41 (6): 308-312.
  13. De Servi S., Guastoni C., Mariani M. et al. Chronic renal failure in acute coronary syndromes. G Ital Cardiol (Rome) 2006; 7 (4 Suppl 1): 30S-35S.
  14. Wright R.S., Reeder G.S., Herzog C.A. et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002; 137 (7): 563-570.
  15. Sabatine M.S., Cannon C.P., Gibson G.M. et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with st-segment elevation. N Engl J Med 2005; 352: 1179-1189.
  16. Maeder M., Klein M., Fehr T. et al. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-1771.
  17. Оганов Р.Г., Мамедов М.Н. Функциональное состояние почек и прогнозирование сердечно-сосудистого риска. В кн: Национальные клинические рекомендации. М: МЕДИ экспо 2009: 77-98.
  18. Levey A.S., Bosch J.P., Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
  19. Masoudi F.A., Plomondon M.E., Magid D.J. et al. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J 2004; 147: 623-629.
  20. Van Domburg R.T., Sonnenschein K., Nieuwlaat R. et al. Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction. J Am Coll Cardiol 2005; 46: 15-20.
  21. Козловский В., Руммо В. Реабилитация больных после инфаркта миокарда. Мед вестн 2006; 1.
  22. Донецкая О.П., Евдокимова М.А., Осмоловская В.С. и др. Прогностическая значимость мерцательной аритмии у перенесших острый коронарный синдром больных. Кардиология 2009; 1: 19-24.
  23. Kornovski R., Goldbourt U., Boyko V., Behar S. and SPRINT Group. Clinical predictors of reinfarction among men and women after a first myocardial infarction. Cardiology 1995; 86 (2): 163-168.

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies